Hulley S - Search Results

1

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D; HERS Research Group. Hulley S, et al. JAMA. 2002 Jul 3;288(1):58-66. doi: 10.1001/jama.288.1.58. JAMA. 2002. PMID: 12090863 Clinical Trial.

2

Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).

Shlipak MG, Chaput LA, Vittinghoff E, Lin F, Bittner V, Knopp RH, Hulley SB; Heart and Estrogen/progestin Replacement Study Investigators. Shlipak MG, et al. Am Heart J. 2003 Nov;146(5):870-5. doi: 10.1016/S0002-8703(03)00412-5. Am Heart J. 2003. PMID: 14597937 Clinical Trial.

3

Predictors of heart failure among women with coronary disease.

Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG. Bibbins-Domingo K, et al. Circulation. 2004 Sep 14;110(11):1424-30. doi: 10.1161/01.CIR.0000141726.01302.83. Epub 2004 Sep 7. Circulation. 2004. PMID: 15353499

4

Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease.

Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG. Bibbins-Domingo K, et al. Am J Cardiol. 2005 Jan 15;95(2):289-91. doi: 10.1016/j.amjcard.2004.09.021. Am J Cardiol. 2005. PMID: 15642574

5

Postmenopausal hormone therapy: does it cause incontinence?

Steinauer JE, Waetjen LE, Vittinghoff E, Subak LL, Hulley SB, Grady D, Lin F, Brown JS. Steinauer JE, et al. Among authors: hulley sb. Obstet Gynecol. 2005 Nov;106(5 Pt 1):940-5. doi: 10.1097/01.AOG.0000180394.08406.15. Obstet Gynecol. 2005. PMID: 16260510 Free PMC article. Clinical Trial.

6

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group. Grady D, et al. Among authors: hulley s. JAMA. 2002 Jul 3;288(1):49-57. doi: 10.1001/jama.288.1.49. JAMA. 2002. PMID: 12090862 Clinical Trial.

7

Postmenopausal hormone treatment.

Hulley S, Grady D. Hulley S, et al. JAMA. 2009 Jun 17;301(23):2493-5. doi: 10.1001/jama.2009.847. JAMA. 2009. PMID: 19531791 No abstract available.

8

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Hulley S, et al. JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605. JAMA. 1998. PMID: 9718051 Clinical Trial.

9

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S. Grady D, et al. Among authors: hulley s. Ann Intern Med. 2000 May 2;132(9):689-96. doi: 10.7326/0003-4819-132-9-200005020-00002. Ann Intern Med. 2000. PMID: 10787361 Clinical Trial.

10

Venous thromboembolic events associated with hormone replacement therapy.

Grady D, Hulley SB, Furberg C. Grady D, et al. Among authors: hulley sb. JAMA. 1997 Aug 13;278(6):477. JAMA. 1997. PMID: 9256219 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page